BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16343861)

  • 1. Striatal dopamine D2/D3 receptor availability in male smokers.
    Yang YK; Yao WJ; McEvoy JP; Chu CL; Lee IH; Chen PS; Yeh TL; Chiu NT
    Psychiatry Res; 2006 Jan; 146(1):87-90. PubMed ID: 16343861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The correlation between striatal dopamine D2/D3 receptor availability and verbal intelligence quotient in healthy volunteers.
    Guo JF; Kuang Yang Y; Tsing Chiu N; Lieh Yeh T; See Chen P; Lee IH; Lin Chu C
    Psychol Med; 2006 Apr; 36(4):547-54. PubMed ID: 16359604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varenicline increases striatal dopamine D(2/3) receptor binding in rats.
    Crunelle CL; Miller ML; de Bruin K; van den Brink W; Booij J
    Addict Biol; 2009 Sep; 14(4):500-2. PubMed ID: 19650815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of Cotard syndrome: (123)I-IBZM SPECT imaging of striatal D(2) receptor binding.
    De Risio S; De Rossi G; Sarchiapone M; Camardese G; Carli V; Cuomo C; Satta MA; Di Giuda D
    Psychiatry Res; 2004 Jan; 130(1):109-12. PubMed ID: 14972373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography.
    Videbaek C; Toska K; Friberg L; Holm S; Angelo HR; Knudsen GM
    J Cereb Blood Flow Metab; 2001 Jan; 21(1):92-7. PubMed ID: 11149673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test-retest variability and reliability of 123I-IBZM SPECT measurement of striatal dopamine D2 receptor availability in healthy volunteers and influence of iterative reconstruction algorithms.
    Catafau AM; Bullich S; Danús M; Penengo MM; Cot A; Abanades S; Farré M; Pavía J; Ros D
    Synapse; 2008 Jan; 62(1):62-9. PubMed ID: 17960766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of sex differences in striatal dopamine D2 receptor binding in drug-naive schizophrenic patients: an IBZM-SPECT study.
    Parellada E; Lomeña F; Catafau AM; Bernardo M; Font M; Fernández-Egea E; Pavía J; Gutierrez F
    Psychiatry Res; 2004 Jan; 130(1):79-84. PubMed ID: 14972370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study.
    Pogarell O; Koch W; Pöpperl G; Tatsch K; Jakob F; Zwanzger P; Mulert C; Rupprecht R; Möller HJ; Hegerl U; Padberg F
    J Psychiatr Res; 2006 Jun; 40(4):307-14. PubMed ID: 16259998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Greater availability of dopamine transporters in patients with major depression--a dual-isotope SPECT study.
    Yang YK; Yeh TL; Yao WJ; Lee IH; Chen PS; Chiu NT; Lu RB
    Psychiatry Res; 2008 Apr; 162(3):230-5. PubMed ID: 18295460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal D₂ receptor binding in 22q11 deletion syndrome: an [¹²³I]IBZM SPECT study.
    Boot E; Booij J; Zinkstok JR; de Haan L; Linszen DH; Baas F; van Amelsvoort TA
    J Psychopharmacol; 2010 Oct; 24(10):1525-31. PubMed ID: 19406852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesia.
    Martikainen IK; Hagelberg N; Mansikka H; Hietala J; Någren K; Scheinin H; Pertovaara A
    Neurosci Lett; 2005 Mar; 376(3):149-53. PubMed ID: 15721212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal dopamine D2/3 receptor availability increases after long-term bariatric surgery-induced weight loss.
    van der Zwaal EM; de Weijer BA; van de Giessen EM; Janssen I; Berends FJ; van de Laar A; Ackermans MT; Fliers E; la Fleur SE; Booij J; Serlie MJ
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1190-200. PubMed ID: 27184782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between striatal dopamine D2 receptor density and neuroticism in community volunteers.
    Lee IH; Cheng CC; Yang YK; Yeh TL; Chen PS; Chiu NT
    Psychiatry Res; 2005 Apr; 138(3):259-64. PubMed ID: 15854793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased dopamine transporter availability in male smokers -- a dual isotope SPECT study.
    Yang YK; Yao WJ; Yeh TL; Lee IH; Chen PS; Lu RB; Chiu NT
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):274-9. PubMed ID: 17900774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sunshine-exposure variation of human striatal dopamine D(2)/D(3) receptor availability in healthy volunteers.
    Tsai HY; Chen KC; Yang YK; Chen PS; Yeh TL; Chiu NT; Lee IH
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):107-10. PubMed ID: 20875835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in striatal dopamine D2/D3 receptor availability in smokers and non-smokers.
    Brown AK; Mandelkern MA; Farahi J; Robertson C; Ghahremani DG; Sumerel B; Moallem N; London ED
    Int J Neuropsychopharmacol; 2012 Aug; 15(7):989-94. PubMed ID: 22243762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPECT tracer [(123)I]IBZM has similar affinity to dopamine D2 and D3 receptors.
    Videbaek C; Toska K; Scheideler MA; Paulson OB; Moos Knudsen G
    Synapse; 2000 Dec; 38(3):338-42. PubMed ID: 11020237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity.
    van de Giessen E; Celik F; Schweitzer DH; van den Brink W; Booij J
    J Psychopharmacol; 2014 Sep; 28(9):866-73. PubMed ID: 24785761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between striatal dopamine D2/D3 receptor binding and cardiovascular activity in healthy subjects.
    Yeh TL; Yang YK; Chiu NT; Yao WJ; Yeh SJ; Wu JS; Chuang JI; Chang SH
    Am J Hypertens; 2006 Sep; 19(9):964-9. PubMed ID: 16942941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence.
    Ballard ME; Mandelkern MA; Monterosso JR; Hsu E; Robertson CL; Ishibashi K; Dean AC; London ED
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu119. PubMed ID: 25603861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.